EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study

Stella van der Graaff iD, Tessa A M Backhuijs, Frank P de Kort, Elize W Lockhorst, Huberdina P M Smedts iD, Jennifer M J Schreinemakers, Gatske M Nieuwenhuyzen-de Boer, Janneke S Hoogstad-van Evert iD

Cancers · 22.04.2025 · 17 (9) · 1393

DOI: 10.3390/cancers17091393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 22.04.2025. Verfasst von Stella van der Graaff und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Amphia Hospital, 4818 CK Breda, The Netherlands. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amphia Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytoreductive surgery (CRS), in combination with chemotherapy, is the main treatment for advanced-stage ovarian cancer. In vulnerable patients, this extensive surgery has a high complication risk and may lead to clinical decline. There is emerging evidence that prehabilitation could be valuable in optimizing the patient’s condition prior to cytoreductive surgery, as is shown in colorectal surgery. However, there is limited evidence in gynecologic oncology. The objective of this study is to evaluate the feasibility and effects of implementing multimodal prehabilitation before cytoreductive surgery in patients with ovarian cancer.

Methods

In two Dutch hospitals, 46 patients with ovarian cancer were included during the study period, of whom 32 participated in a multimodal prehabilitation program before CRS. The programs included at least physiotherapy, dietary advice and intoxication cessation. The timing, extent and content of the programs differed. Feasibility was assessed by eligibility and participation rates and adherence to the physiotherapy program. Effectiveness was measured by differences in functional capacity, postoperative outcomes and tolerance to adjuvant chemotherapy.

Results

Eligibility rates in both hospitals were 83% and 89%, and participation rates were 68% and 72%. Adherence to the physiotherapy program was moderate and only satisfactory in 55% and 63% of the patients. All fitness endpoint measurements improved compared to the baseline. No significant differences in postoperative outcomes were found between prehabilitation and control patients. Prehabilitation patients appeared to have better tolerance to adjuvant chemotherapy, with fewer dose reductions (21% vs. 73%, p = 0.017) and dose deferrals (39% vs. 46%, not significant) compared to the control group.

Conclusions

The implementation of multimodal prehabilitation before CRS is feasible and effective in patients with ovarian cancer with respectable eligibility and participation rates, along with improved functional capacity, even during neoadjuvant chemotherapy.

Schlagwörter

Stichwörter der Autor:innen

cytoreductive surgeryfeasibilityovarian cancerperioperative careprehabilitation

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Amphia Hospital, 4818 CK Breda, The Netherlands.
  • Department of Sports Medicine, Amphia Hospital, 4818 CK Breda, The Netherlands.
  • Department of Physiotherapy, Albert Schweitzer Hospital, 3318 AT Dordrecht, The Netherlands.
  • Department of Surgery, Amphia Hospital, 4818 CK Breda, The Netherlands.
  • Department of Gynecology and Obstetrics, Albert Schweitzer Hospital, 3318 AT Dordrecht, The Netherlands.
  • Department of Gynecological Oncology, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.

ORCID-Profile: Stella van der Graaff, Huberdina P M Smedts, Janneke S Hoogstad-van Evert

Förderung

  • Amphia Science Fund

Zitieren

APA

van der Graaff, S., Backhuijs, T. A. M., de Kort, F. P., Lockhorst, E. W., Smedts, H. P. M., Schreinemakers, J. M. J., Nieuwenhuyzen-de Boer, G. M., & Hoogstad-van Evert, J. S. (2025). Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study. Cancers, 17(9), 1393. https://doi.org/10.3390/cancers17091393

Vancouver

van der Graaff S, Backhuijs TAM, de Kort FP, Lockhorst EW, Smedts HPM, Schreinemakers JMJ, et al. Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study. Cancers. 2025;17(9):1393. doi:10.3390/cancers17091393

BibTeX
@article{vanderGraaff2025,
  author = {van der Graaff, Stella and Backhuijs, Tessa A M and de Kort, Frank P and Lockhorst, Elize W and Smedts, Huberdina P M and Schreinemakers, Jennifer M J and Nieuwenhuyzen-de Boer, Gatske M and Hoogstad-van Evert, Janneke S},
  title = {Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1393},
  doi = {10.3390/cancers17091393}
}
Kostenlos starten →